Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

20%

1 of 5 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 2
1(20.0%)
5Total
N/A(4)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03730610Not ApplicableCompleted

Systemic Cross-talk Between Brain, Gut, and Peripheral Tissues in Glucose Homeostasis: Effects of Exercise Training

Role: collaborator

NCT00179777Not ApplicableCompleted

TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk

Role: collaborator

NCT03563287Not ApplicableCompleted

Effects of LRYGB on Pharmacokinetics of Nine CYP Probe Drugs

Role: collaborator

NCT01479933Not ApplicableCompleted

Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes

Role: collaborator

NCT00570102Phase 2Completed

Nutritional Prevention Pilot Trial for Type 1 Diabetes

Role: collaborator

All 5 trials loaded